In total, 2 patients had FLT3 gene mutations, 1 of which was classified as AML-M3 and interestingly the FLT3-D835 mutation was not a deletion, but a point mutation (g.IVS20 +49 A>G) that also changed the EcoRV restriction site. This evidence concerns the gene FLT3 and acute myeloid leukemia.